In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...
The company submission assumes that red blood cell transfusions are typically given every 6 weeks ... Then, the CRISPR associated protein 9 is used to edit the BCL11A gene before the cells are frozen.